New treatment for atopic dermatitis shows promising result \
4 min read
\
\

New treatment for atopic dermatitis shows promising result

10-Dec-2022
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.
10-Dec-2022 Health
\
Inflammation a significant factor contributing to Alzheimer’s disease: Study \
6 min read
\
\

Inflammation a significant factor contributing to Alzheimer’s disease: Study

01-Dec-2022
An important cause of Alzheimer's disease inflammation has recently been linked to a gene that is prevalent in the brain's cleaning cells, called microglia, according to a recent study. The discovery might offer a brand-new area of focus for treatments of the incurable disease.
01-Dec-2022 Health
\
Lung cancer screening helps to increase survival rate of cancer patients \
5 min read
\
\

Lung cancer screening helps to increase survival rate of cancer patients

22-Nov-2022
Researchers found lung cancer screenings useful to increase survival rate of cancer patients. Early-stage lung cancer is detected by low-dose computed tomography (CT) screening.
22-Nov-2022 Health
\
Study finds treatment options for patients whose blood cancer relapses after CAR-T \
3 min read
\
\

Study finds treatment options for patients whose blood cancer relapses after CAR-T

06-Nov-2022
The study discovered new treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.
06-Nov-2022 Health
\
Researchers find treatment options for patients whose blood cancer relapses after CAR-T \
3 min read
\
\

Researchers find treatment options for patients whose blood cancer relapses after CAR-T

04-Nov-2022
Researchers have identified therapies that can help patients with multiple myeloma blood cancer who try an immunotherapy known as CAR-T only to find their cancer returning afterwards.
04-Nov-2022 Health
\
New tool discovered for estimating people’s total exposure to potentially harmful chemicals \
5 min read
\
\

New tool discovered for estimating people’s total exposure to potentially harmful chemicals

03-Nov-2022
A novel metric that estimates our "burden," or cumulative exposure, to a family of thousands of synthetic chemicals that we encounter in everyday life with potentially adverse health impacts, has been created by a team of researchers at Mount Sinai.
03-Nov-2022 Science
\
Researchers discover new way to reverse effects of neurological disease in patient cells, mice \
4 min read
\
\

Researchers discover new way to reverse effects of neurological disease in patient cells, mice

09-Sep-2022
Washington [US], September 9 (ANI): Scientists at Mount Sinai's Icahn School of Medicine, the National Center for Advancing Translational Sciences (NCATS), and other institutions have reversed the effects of several life-threatening inherited neurodegenerative diseases known as lysosomal storage disorders (LSDs) in patient cells and mice.
09-Sep-2022 Health
\
Researchers report encouraging immunotherapy options for relapsed myeloma patients \
4 min read
\
\

Researchers report encouraging immunotherapy options for relapsed myeloma patients

02-Sep-2022
Washington [US], September 2 (ANI): Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time -- they are meant to enhance the immune system's destruction of tumour cells.
02-Sep-2022 Science
\
Specific environmental exposures might help predict death risk from cardiovascular disease: Research \
5 min read
\
\

Specific environmental exposures might help predict death risk from cardiovascular disease: Research

26-Jun-2022
Washington [US], June 26 (ANI): A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 per cent.
26-Jun-2022 Science
\
Durability and effectiveness of immune response against COVID-19: Study \
4 min read
\
\

Durability and effectiveness of immune response against COVID-19: Study

23-May-2022
Washington [US], May 23 (ANI): In multiple studies from eight cohorts across the United States, a group of researchers accelerated the collection of essential data to answer questions about the immune response needed for long-term protection against SARSCoV2.
23-May-2022 Science
\